Filing Flows › Tela Bio (TELA) › Q1 2026 › vs Q1 2025
Tela Bio (TELA) Q1 2026 vs Q1 2025 (year over year)
Tela Bio's revenue rose $539K (+3%) from $18.5M in Q1 2025 to $19.1M in Q1 2026.
Tela Bio, Q1 2026: revenue $19.1M (+3% year over year), operating margin -55.2%, net loss $12.3M, operating cash flow −$11.2M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $19.1M | $18.5M | $539K | +3% |
| Net loss | $12.3M | $11.3M | $1.0M | +9% |
| Costs & expenses | $31.3M | $29.8M | $1.5M | +5% |
| Operating costs | $29.6M | $29.0M | $593K | +2% |
| Interest & other, net | $1.7M | $740K | $947K | +128% |
| Income tax | $60K | $52K | $8K | +15% |
| Cost of revenue | $6.5M | $6.0M | $531K | +9% |
| Research & development | $2.3M | $2.5M | −$197K | -8% |
| Sales & marketing | $16.5M | $16.6M | −$71K | -0.4% |
| General & admin | $4.2M | $3.8M | $330K | +9% |
| Operating cash sources | $12.3M | $11.3M | $1.0M | +9% |
| Depreciation | $169K | $172K | −$3K | -2% |
| Share-based compensation | $816K | $1.0M | −$228K | -22% |
| Working capital & other | $118K | $323K | −$205K | -63% |
| Cash used in operations | $11.2M | $9.7M | $1.4M | +15% |
| Net loss absorbed | $12.3M | $11.3M | $1.0M | +9% |
Questions
How much did Tela Bio's revenue grow year over year in Q1 2026?
Tela Bio's revenue rose $539K (+3%) from $18.5M in Q1 2025 to $19.1M in Q1 2026.